News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Yuyu Pharma attendance at European Pharmaceutical Conference
Friday, November 04, 2022Yuyu Pharmas CEO Robert Yu has been actively participating in biopharmaceutical conferences specifically BIOEurope in Leipzig and CPHI in Frankfurt held in Germany
QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform
Thursday, November 03, 2022QuantuMDx Group Limited a UKbased developer of transformational PointofNeed molecular diagnostics and AMenarini Diagnostics SrI Menarini are pleased to announce an exclusive distribution agreement for QuantuMDxs QPOC platform in the UK and France
OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
Thursday, November 03, 2022OrsoBio Inc a clinicalstage biopharmaceutical company developing treatments for severe metabolic disorders today announced its acquisition of assets relating to the Liver X Receptor LXR inverse agonist program from Phenex Pharmaceuticals including le...
Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Wednesday, November 02, 2022Lonza a preferred partner to the pharmaceutical biotech and nutraceutical markets has launched an innovative new capsule solution for intestinal enteric drug delivery The Capsugel Enprotect capsule does not disintegrate during stomach transit and onl...
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform
Wednesday, November 02, 2022Stevanato Group SpA a global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries and Gerresheimer AG a leading global provider of healthcare beauty and drug delivery sy...
Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028
Tuesday, November 01, 2022Small Pharma Inc a biotechnology company focused on shortacting psychedelicassisted therapies for mental health conditions today announces that it has received approval from the UK Medicines and Healthcare products Regulatory Authority the MHRA and t...
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis
Tuesday, November 01, 2022Karyopharm Therapeutics Inc a pharmaceutical company specializing in innovative cancer therapies and the Menarini Group a leading international pharmaceutical company announced today that the European
Melt Pharmaceuticals Announces Dosing of Last Patient in Phase 2 Pivotal Efficacy and Safety Study for MELT-300
Monday, October 31, 2022Melt Pharmaceuticals Inc a clinicalstage pharmaceutical company dedicated to developing innovative solutions for procedural sedation and analgesia has announced the completion of patient dosing in its Phase pivotal efficacy and safety study for its...
Inventiva provides an update on the development of cedirogant by AbbVie
Monday, October 31, 2022Inventiva a clinicalstage biopharmaceutical company specializing in the development of oral small molecule therapies made an announcement regarding the discontinuation of cedirogant ABBV an oral RORg inverse agonist developed in collaboration with Ab...
ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
Friday, October 28, 2022ProBioGen and Thermo Fisher Scientific have joined forces once again building upon the success of the Gibco Freedom CHOS Cell Line Development Kit to introduce an enhanced platform called the Gibco Freedom ExpiCHOS Cell Line Development Kit This adva...
